Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

NCT00420212 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1234

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: BG00012
DRUG: Placebo

Sponsor

Biogen